EVIO Inc. performs Full Compliance Testing for California as Steep Hill, CA

[ACCESSWIRE]

HENDERSON, NV / ACCESSWIRE / April 21, 2021 / EVIO Inc. (the "Company" or "EVIO") (OTC PINK:EVIO), is excited to announce the launch of full compliance cannabis testing in conjunction with our subsidiary, C3 Labs, LLC dba Steep Hill CA.

In September 2020, C3 Labs, LLC merged lab operations with Steep Hill CA to operate in its new 35,200 square foot laboratory at 2448 6^th St. Berkeley, CA. Steep Hill CA was founded as the nation's first cannabis testing laboratory in 2008. Now the combined laboratory serves as one of the largest square foot and total capacity cannabis testing labs globally and applies best practices from both the EVIO and Steep Hill family of laboratories. The lab is licensed with the California Bureau of Cannabis Control and accredited to ISO 17025 standards.

All cannabis products sold in licensed dispensaries in California must be tested by a licensed laboratory such as Steep Hill CA. The state of California has over 1,000 active licensed cannabis distributors that distribute products to licensed retailers statewide. The combined laboratory is fully equipped to provide the testing services required to distribute cannabis products to licenced dispensaries.

The merger of the two laboratories provides additional redundant lab instrumentation needed for high-capacity testing with fast turnaround times. This aids to provide a competitive advantage in the California marketplace, in which many labs lack redundancy.

Continued Hemp Initiatives

The laboratory is also the new center for www.hemptesting.com, which performs testing for CBD and hemp derived products for clients worldwide. The lab performs both potency testing and safety testing to detect the presence of harmful contaminants such as pesticides, heavy metals, microbial contaminants, and residual solvents. The Hemp and CBD Safety Panel test focuses on providing manufacturers and distributors a comprehensive suite of tests that gives clients the utmost confidence in the purity and potency of their products. The company anticipates both hemp and CBD trends to continue, further expanding EVIO's market position.

About EVIO Inc.

EVIO Labs is a provider of cannabis, hemp, and CBD testing. EVIO maintains licensed and accredited cannabis, CBD, and hemp full-service testing laboratory operations, and provides clients with quality analytical, R&D, and consulting services to produce the best, compliant products. EVIO provides quality assurance to consumers that the potency listed on the label matches what is in the package, and that the product is free of harmful contaminants.

For more information, visit www.eviolabs.com.

Safe Harbor Statement

Any statements in this press release that are not statements of historical fact may be considered forward-looking statements pertaining to anticipated or projected plans, performance, and developments, as well as other statements relating to future operations and results. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only, and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, the Company's ability to complete product testing and launch product commercially, the acceptance of product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in Company reports filed with the Securities and Exchange Commission, available at www.sec.gov or www.eviolabs.com.

For Further Information:

Lori Glauser, CEO
[email protected]
702-748-9944

SOURCE: EVIO, Inc.